Glenn A. Oclassen
2011
In 2011, Glenn A. Oclassen earned a total compensation of $1.9M as President and Chief Executive Officer at Paratek Pharmaceuticals, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $227,500 |
|---|---|
| Option Awards | $1,175,720 |
| Salary | $450,833 |
| Total | $1,854,053 |
Oclassen received $1.2M in option awards, accounting for 63% of the total pay in 2011.
Oclassen also received $227.5K in non-equity incentive plan and $450.8K in salary.
Rankings
In 2011, Glenn A. Oclassen's compensation ranked 3,545th out of 10,747 executives tracked by ExecPay. In other words, Oclassen earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,545 out of 10,747 | 67th |
Division Manufacturing | 1,240 out of 3,960 | 69th |
Major group Chemicals And Allied Products | 245 out of 1,038 | 76th |
Industry group Drugs | 139 out of 786 | 82nd |
Industry Pharmaceutical Preparations | 116 out of 571 | 80th |
Source: SEC filing on April 24, 2012.
Oclassen's colleagues
We found four more compensation records of executives who worked with Glenn A. Oclassen at Paratek Pharmaceuticals in 2011.